Adjuvant treatment of pancreatic cancer

European Journal of Cancer

Volumn 47, Issue SUPPL. 3, 2011, Pages

  Neoptolemos, John P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; DRUG SAFETY; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; PANCREAS CANCER; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNSPECIFIED SIDE EFFECT;

CARCINOMA; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 80053254048     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/S0959-8049(11)70210-6     Document Type: Article

References (16)

1. M Kaiser, S Ellenberg Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899 903 (Pubitemid 15040883)
2. J Neoptolemos, J Dunn, D Stocken et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 358 9293 2001 1576 1585 (Pubitemid 33101907)
3. J Neoptolemos, D Stocken, H Freiss et al. A randomised trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N EnglJ Med 350 2004 1200 1210 (Pubitemid 38339364)
4. R Carter, DD Stocken, P Ghaneh et al.; for the European Study Group for Pancreatic Cancer (ESPAC). Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer - subset analysis of the ESPAC-1 data Int J Cancer 124 2009 2960 2965
5. K Bakkevold, B Arnesjo, O Dahl, B Kambestad Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomised multicentre study Eur J Can 29A 5 1993 698 703 (Pubitemid 23077048)
6. G Butturini, DD Stocken, MN Wente on behalf of the Pancreatic Cancer Meta-analysis Group The influence of resection margins and treatment on survival for patients with pancreatic cancer within a meta-analysis of randomized controlled trials Arch Surg 143 2008 75 83 (Pubitemid 351159303)
7. J Klinkenbijl, J Jeekel, T Sahmoud et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region Ann Surg 230 1999 776 784
8. HG Smeenk, CHJ Van Eijck, WC Hop et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC Trial 40891 Ann Surg 246 2007 734 740 (Pubitemid 350035648)
9. WF Régine, KA Winter, RA Abrams et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial JAMA 299 2008 1019 1026 (Pubitemid 351347058)
10. H Oettle, S Post, P Neuhaus, K Geliert et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 2007 267 277 (Pubitemid 46143304)
11. H Ueno, T Kosuge, Y Matsuyama et al. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer Br J Cancer 101 2009 908 915
12. JP Neoptolemos, DD Stocken, C Bassi European Study Group for Pancreatic Cancer Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JAMA 304 10 2010 1073 1081
13. JP Neoptolemos, DD Stocken, C Tudur Smith for the European Study Group of Pancreatic Cancer Adjuvant 5-fluorouracil and folinic acid versus observation for pancreatic cancer: composite data from the ESPAC-1 and -3(vl) trials Br J Cancer 100 2 2009 246 250
14. R Twombly Adjuvant chemoradiation for pancreatic cancer: few good data, much debate JNatl Cancer Inst 100 2008 1670 1671
15. EM O'Reilly Refinement of adjuvant therapy for pancreatic cancer JAMA 304 2010 1124 1125
16. D Cunningham, I Chau, DD Stocken et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer J Clin Oncol 27 2009 5513 5518